Tnik inhibitor and the use
OwnerTesshi YAMADA, Miki SHITASHIGE +3inventors
InventorsTesshi YAMADA, Miki SHITASHIGE, Koichi YOKOTA, Masaaki SAWA, Hideki MORIYAMA
Life of this patent
Estimating the term…
Loading patent…
OwnerTesshi YAMADA, Miki SHITASHIGE +3inventors
InventorsTesshi YAMADA, Miki SHITASHIGE, Koichi YOKOTA, Masaaki SAWA, Hideki MORIYAMA
Estimating the term…
The present invention relates to compositions and methods for the treatment of cancer patients with Traf2- and Nck-interacting kinase (TNIK) inhibitors. More particularly, the present invention relates to pharmaceutical compositions comprising TNIK inhibitor and a pharmaceutically acceptable carrier, and to methods for treating the TNIK inhibitor administered to cancer patients, especially to solid cancer patients such as colorectal cancer, pancreatic cancer, non-small cell lung cancer, prostate cancer or breast cancer. And the present invention relates to a novel aminothiazole derivatives.
A TNIK inhibitor comprising a compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient:
A compound represented by the following general formula:
Dependencies are inferred from the claim text.